Invest in the Future of Diagnostic Solutions

We are building a tool ready to make diagnostic evaluation for autism faster, more accurate and cheaper.

Contact Us
Download Our Corporate Presentation

BlinkLab Dx 1 is a smartphone-based platform seeking FDA 510(k) clearance. Our goal is to aid clinicians and empower parents in detecting developmental concerns early, ultimately improving outcomes for children.

Call for action

Autism prevalence has surged over 2% among children, according to the CDC and WHO.

The challenge

Governments and healthcare providers are urgently seeking new technologies to accelerate diagnostics, enhance accuracy, and reduce medical costs.

Our solution

BlinkLab is at the forefront, delivering a neuroscience-powered, tech-driven, and accessible solution designed to facilitate early diagnosis in young children.

Watch the interview with Brian Leedman, chair of our board.

Our stock

BlinkLab ASX:BB1

Stock price (AUD)

-

Market cap (AUD)

-

Volume Today

-

Select date range:

We've been featured in the media

Discover what the press is saying about us. Check out our latest media mentions and see how we’re making an impact.

View media mentions

Our pipeline

Our R&D pipeline is focused on securing FDA 510(k) clearance and EU regulatory approval for BlinkLab Dx 1 as a diagnostic adjunct for autism and ADHD, positioning it as a transformative tool for early detection.

Product
Name
Product
Description
Clinical Feasibility
Studies
Pivotal Clinical
Studies
Regulatory
Approval
Post
Authorization
BlinkLab Dx 1
Autism diagnostic adjunct
BlinkLab Dx N
ADHD diagnostic adjunct
Scroll to see more

Meet our team!

Our team combines clinical expertise, scientific rigor, and smart solutions to drive innovation.

Management
Research Team
Board
Scientific Advisory Board
Bas Koekkoek, PhD

CSO - Co-founder

Peter Boele, MA

CTO - Co-founder

Henk-Jan Boele, MD PhD

CEO - Co-founder

Seth Sherry

Director of Operations

Emily Soong

Clinical Research Manager

Sander Lindeman, PhD

Developer

Kayleigh Gultig

Clinical Research Associate

Lotte Roggeveen

Clinical Research Manager

Paul Ravi Frölke

Data Scientist

Anton Uvarov, MBA PhD

Executive Director - Co-founder

Brian Leedman, MBA

Non-Executive Chairman

Jane Morgan

Non-Executive Director

Richard Hopkins, PhD

Non-Executive Director

Abdeslem El Idrissi, PhD

Professor, College University New York

María Vinueza-Veloz, MD PhD

Postdoctoral fellow, University of Oslo

Chris de Zeeuw, MD PhD

Professor, Erasmus MC

Sam Wang, PhD

Professor, Princeton University

Javier Medina, PhD

Professor, Baylor College of Medicine

Meet our team!
Henk-Jan Boele BlinkLab CEO
Henk-Jan Boele
MD, PhD Neuroscience

"For me it's gratifying to apply neuroscience for improving autism diagnosis and care."

Dr. Henk-Jan Boele, co-founder of BlinkLab, leads a team of neuroscientists, medical doctors, and software developers to bring this mission to life. Founded as a Princeton University startup in 2021, BlinkLab went public on the ASX (ASX:BB1) in April 2024 and is now seeking FDA clearance for its first diagnostic product.

Watch the interview with Henk-Jan

Latest ASX
Announcements

Read more about what
we've been doing!

View all articles
Peter Boele, MA
•
January 14, 2025

How Exercise Boosts Learning: Insights from Associative Conditioning

Exploring the link between acute aerobic activity, brain function, and learning potential in regular and non-regular exercisers

Henk-Jan Boele, MD PhD
•
December 26, 2024

Positive outcome received from a Pre-Submission meeting with the FDA regarding the regulatory pathway for BlinkLab Dx 1 diagnostic app.

BlinkLab is thrilled to share the successful outcome of its Pre-Submission meeting with the FDA, marking a critical step toward achieving 510(k) clearance for its innovative autism diagnostic app, BlinkLab Dx 1. With the study design and data requirements now confirmed, BlinkLab is poised to initiate a robust clinical program that will pave the way for regulatory approval and market entry in the US.

Peter Boele, MA
•
December 26, 2024

Improving kids autism and ADHD diagnoses through BlinkLab collaboration with Monash University

BlinkLab partners with Monash University for a two-year MAGNET project to enhance autism and ADHD diagnosis using app-based AI technology.

Awesome! You're now signed up.

You will receive our newsletter. You can opt out via the newsletter.

Oops! Something went wrong while submitting the form.
Or see our media mentions:

East Coast Research

Leadership Talks with BlinkLab (ASX:BB1) CEO & Co-Founder Henk-Jan Boele

The Australian

BlinkLab initiates first US clinical sites for autism registrational study

Stockhead

BlinkLab initiates first US clinical sites for autism registrational study

Help us improve diagnostic evaluations for autism!

Let's make developmental diagnostic evaluation more efficient and accessible.

Participate in our study

Join our newsletter!

And stay up to date with the latest developments of our product!

Awesome! You're now signed up.

You will receive our newsletter. You can opt out via the newsletter.

Oops! Something went wrong while submitting the form.
Privacy Policy
•
Mobile Privacy Policy
•
Cookie Policy
Copyright BlinkLab LTD
•
Overflow Agency